Exhibit 4.3.6


 


GAN
LIMITED


 


2020
EQUITY INCENTIVE PLAN UK SUB-PLAN


COMPANY
SHARE OPTION PLAN OPTION AGREEMENT


 


The
Company hereby grants an Option to purchase Shares to the Optionee named below. The terms and conditions of the Option are set
forth in this cover sheet and the attached Company Share Option Plan Option Agreement (together, this “Agreement”)
and in the GAN Limited 2020 Equity Incentive Plan UK Sub-Plan (CSOP) as it may be amended from time to time. Unless otherwise
defined in this Agreement, certain capitalized terms used in this cover sheet and Agreement are defined in the UK CSOP Schedule.


 


Date
of Option Grant: __________________, [YEAR]


 


Name
of Optionee: _________________________________________________


 


Number
of Shares Covered by Option: ______________


 


Exercise
Price per Share: $_____.___


 


Market
Value of a Share on Date of Option Grant: $_____.___


 


Normal
Exercise Date: _____________, [YEAR] [INSERT DATE THAT IS ON OR AFTER THE THIRD ANNIVERSARY OF THE DATE OF GRANT]


 


Expiration
Date: _____________, [YEAR] [DO NOT EXCEED TEN YEARS FROM GRANT] This Option will expire earlier as a result of certain
events, including your Termination of Employment, as provided in this Agreement.


 


Vesting
Calculation Date: _____________, [YEAR]


 


Vesting
Schedule:


 


Subject
to all the terms of this Agreement and you continuing to be an Employee through the applicable Vesting Dates, your right to purchase
Shares under this Option shall incrementally vest [as to 25% of the total number of Shares covered by this Option, as shown above,
on each of the first four anniversaries of the Vesting Calculation Date.] OR [INSERT OTHER VEST SCHEDULE] In all cases, the resulting
aggregate number of Vested Shares will be rounded down to the nearest whole number. Upon ceasing to be an Employee at any time
and for any reason or no reason, all of the then outstanding unvested portion of this Option shall be forfeited to the Company
without consideration as of your termination date. No partial vesting credit will be provided no matter when your termination
date occurs.


 


By
signing this Agreement, you agree to all of the terms and conditions described in this Agreement, the Plan and the UK CSOP Schedule.
You are also acknowledging receipt of this Agreement and a copy of the Plan, the UK CSOP Schedule and the Plan’s prospectus.
Any inconsistency between this Agreement and the Plan UK and the CSOP Schedule shall be resolved by reference to the Plan and
the UK CSOP Schedule.


 




    	 



    	 



    

 


This
Agreement has been executed as a deed and unconditionally delivered on the date first above written.


 


Executed
as a DEED by


 


	Optionee:	__________________________________________________ 	 
	 	(Signature)	 
	 	 	 
	 	In
    the presence of:	 
	 	 	 
	 	Witness
    signature ____________________________________	 
	 	Name
    (in BLOCK CAPITALS) __________________________	 
	 	Address
    ___________________________________________	 
	 	___________________________________________________	 
	 	 	 
	Company	 	 
	Acting
    by a	 	 
	director
    :	__________________________________________________ 	 
	 	(Signature)	 
	 	 	 
	 	Print
    Name ___________________________________	 
	 	 	 
	 	In
    the presence of:	 
	 	 	 
	 	Witness
    signature ____________________________________	 
	 	Name
    (in BLOCK CAPITALS) __________________________	 
	 	Address
    ___________________________________________	 
	 	___________________________________________________	 
	Title:

        
	__________________________________________________ 	 
	Attachment	 	 


 




    	 



    	 



    

 


GAN
LIMITED


 


2020
EQUITY INCENTIVE PLAN UK SUB-PLAN


COMPANY
SHARE OPTION PLAN OPTION AGREEMENT


 


	1.	 	The
    Plan and

    Other Agreements	 	The
        text of the Plan and the UK CSOP Schedule is incorporated in this Agreement by reference. You and the Company agree to
        execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent
        of this Agreement.

         

        This
        Agreement, the Plan and the UK CSOP Schedule constitute the entire understanding between you and the Company regarding
        this Option. Any prior agreements, commitments or negotiations concerning this Option are superseded.

	 	 	 	 	 
	2.	 	Award
    of CSOP Option	 	The
    Company awards you a CSOP Option as shown on the cover sheet to this Agreement. This Option is intended to be a CSOP Option
    under Schedule 4 of the Income Tax (Earnings and Pensions) Act 2003 and will be interpreted accordingly.
	 	 	 	 	 
	3.	 	Vesting
    and Exercise	 	This
    Option is only exercisable before it expires and only with respect to the Vested portion of the Option and in accordance with
    the rules of the UK CSOP Schedule. This Option will Vest according to the Vesting Schedule described in the cover sheet of
    this Agreement.
	 	 	 	 	 
	4.	 	Term	 	Your
    Option will expire in all cases no later than the close of business at Company headquarters on the Expiration Date, as shown
    on the cover sheet. Your Option may expire earlier if you cease to be an Employee (as provided for in rule 7 of the UK CSOP
    Schedule) or as otherwise set out in the rules of the Plan and the UK CSOP Schedule. You are solely responsible for determining
    whether and when to exercise any Vested portion of this Option and also for keeping track of when your Option expires and
    when it therefore can no longer be exercised. The Company has no obligation (and does not intend) to provide you with any
    further notice of your Option’s expiration dates. The Company will have no liability to you or to any other person if
    all or any portion of your Option is not exercised before it expires for any reason.
	 	 	 	 	 
	5.	 	Notice
    of Exercise	 	When
        you wish to exercise this Option, you must notify the Company by filing a “Notice of Exercise” form at the
        address given on the form. Your notice must specify how many Shares you wish to purchase. The notice can only become effective
        after it is received by the Company.

        If
        someone else wants to exercise this Option after your death, that person must prove to the Company’s satisfaction
        that he or she is entitled to do so.




 



    	 



    	 



    

 


	6.	 	Form
    of Payment	 	When
        you submit your notice of exercise, you must include payment of the aggregate Exercise Price for the Shares you are purchasing.
        Payment may be made in one (or a combination) of the following forms:

        




 


	 	 	 	●	Cash received directly from Optionee’s brokerage
account.
	 	 	 	 	 
	 	 	 	●	To
the extent a public market for the Shares exists as determined by the Company, by Cashless Exercise through delivery (on a form
prescribed by the Company) of an irrevocable direction to a securities broker to sell Shares and to deliver all or part of the
sale proceeds to the Company in payment of the aggregate Exercise Price.
	 	 	 	 	 
	 	 	 	●	To the extent approved by the Committee in its discretion and with all terms and conditions determined
by the Committee, payment may be made in another form of legal consideration acceptable to the Committee and in accordance with
the Plan provided no action is taken that would disqualify the Option from being a CSOP Option.







 


	7.	 	Transfer
    of Award	 	Prior
    to your death, only you may exercise this Option. You cannot gift, transfer, assign, alienate, pledge, hypothecate, attach,
    sell, or encumber this Option. If you attempt to do any of these things, this Option will immediately become invalid. You
    may, however, dispose of this Option in your will or it may be transferred by the laws of descent and distribution. Regardless
    of any marital property settlement agreement, the Company is not obligated to honor a notice of exercise from your spouse,
    nor is the Company obligated to recognize your spouse’s interest in your Option in any other way.
	 	 	 	 	 
	8.	 	Shareholder
    Rights	 	You,
    or your estate, shall have no rights as a shareholder of the Company with regard to the Option until you have been issued
    the applicable Shares by the Company and have satisfied all other conditions specified in the Plan. No adjustment shall be
    made for cash or stock dividends or other rights for which the record date is prior to the date when such applicable Shares
    are issued, except as provided in the Plan.



 






    	 



    	 



    

 


	9.	 	Taxes
    and Withholding	 	You
        will be solely responsible for payment of any and all applicable taxes, including without limitation any penalties or
        interest based upon such tax obligations, associated with this Option.

         

        You
        will not be allowed to exercise this Option unless you make acceptable arrangements to pay any withholding or other taxes
        that may be due as a result of the Option exercise or sale of Shares acquired under this Option as provided for more fully
        in the rules of the Plan and the UK CSOP Schedule.

         

        To
        the extent a public market for the Shares exists as determined by the Company, such withholding taxes may be settled by
        Cashless Exercise through delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker
        to sell Shares and to deliver all or part of the sale proceeds to the Company in payment of the withholding taxes.

         

        To
        the extent approved by the Committee in its discretion and with all terms and conditions determined by the Committee,
        payment of withholding taxes may be made in another form of legal consideration acceptable to the Committee provided no
        action is taken that would disqualify the Option from being a CSOP Option.

	 	 	 	 	 
	10.	 	Restrictions
    on Exercise and Resale	 	By
        signing this Agreement, you agree not to (i) exercise this Option (“Exercise Prohibition”), or (ii)
        sell, transfer, dispose of, pledge, hypothecate, make any short sale of, or otherwise effect a similar transaction of
        any Shares acquired under this Option (each a “Sale Prohibition”) at a time when applicable laws, regulations
        or Company or underwriter trading policies prohibit the exercise or disposition of Shares. The Company will not permit
        you to exercise this Option if the issuance of Shares at that time would violate any law or regulation. The Company shall
        have the right to designate one or more periods of time, each of which generally will not exceed one hundred eighty (180)
        days in length (provided however, that such period may be extended in connection with the Company’s release (or
        announcement of release) of earnings results or other material news or events), and to impose an Exercise Prohibition
        and/or Sale Prohibition, if the Company determines (in its sole discretion) that such limitation(s) is needed in connection
        with a public offering of Shares or to comply with an underwriter’s request or trading policy, or could in any way
        facilitate a lessening of any restriction on transfer pursuant to the Securities Act or any state securities laws with
        respect to any issuance of securities by the Company, facilitate the registration or qualification of any securities by
        the Company under the Securities Act or any state securities laws, or facilitate the perfection of any exemption from
        the registration or qualification requirements of the Securities Act or any applicable state securities laws for the issuance
        or transfer of any securities. The Company may issue stop/transfer instructions and/or appropriately legend any stock
        certificates issued pursuant to this Option in order to ensure compliance with the foregoing. Any such Exercise Prohibition
        shall not alter the Vesting schedule set forth in this Agreement other than to limit the periods during which this Option
        shall be exercisable.

         

        If
        the sale of Shares acquired under this Award is not registered under the Securities Act, but an exemption is available
        which requires an investment representation or other representation and warranty, you shall represent and agree that the
        Shares being acquired are being acquired for investment, and not with a view to the sale or distribution thereof, and
        shall make such other representations and warranties as are deemed necessary or appropriate by the Company and its counsel.

         

        You
        may also be required, as a condition of exercise of this Option, to enter into any Company shareholder agreement or other
        agreements that are applicable to shareholders.




 



    	 



    	 



    

 


	11.	 	Clawback
    Policy	 	You
    expressly acknowledge and agree to be bound by Section 14(e) of the Plan, which contains provisions addressing the Company’s
    policy on recoupment of equity or other compensation.
	 	 	 	 	 
	12.	 	No
    Retention Rights	 	Your
    Option or this Agreement does not give you the right to be retained by the Company Group in any capacity.
	 	 	 	 	 
	13.	 	Extraordinary
    Compensation	 	This
    Option and the Shares subject to the Option are not intended to constitute or replace any pension rights or compensation and
    are not to be considered compensation of a continuing or recurring nature, or part of your normal or expected compensation,
    and in no way represent any portion of your salary, compensation or other remuneration for any purpose, including but not
    limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses,
    long-service awards, pension or retirement benefits or similar payments.
	 	 	 	 	 
	14.	 	Adjustments	 	In
    the event of a stock split, a stock dividend or a similar change in the Company stock, the number of Shares covered by this
    Option (rounded down to the nearest whole number) and the Exercise Price per Share shall be adjusted pursuant to the Plan
    and the UK CSOP Schedule. Your Option shall be subject to the Change of Control provisions set out in the UK CSOP Schedule.
	 	 	 	 	 
	15.	 	Legends	 	All
    certificates or book entries representing the Shares issued under this Award may, where applicable, have endorsed thereon
    the following notations or legends and any other notation or legend the Company determines appropriate:
	 	 	 	 	 
	 	 	 	 	“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND OPTIONS TO PURCHASE SUCH SHARES SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER, OR HIS OR HER PREDECESSOR IN INTEREST. A COPY OF SUCH AGREEMENT IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY AND WILL BE FURNISHED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY BY THE HOLDER OF RECORD OF THE SHARES REPRESENTED BY THIS CERTIFICATE.”

                                                                              

	 	 	 	 	“THE
    SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR QUALIFIED UNDER THE SECURITIES
    LAWS OF ANY STATE, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER
    SUCH ACT OR QUALIFICATION UNDER APPLICABLE STATE LAWS OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL,
    THAT SUCH REGISTRATION OR QUALIFICATION IS NOT REQUIRED.”



 



    	 



    	 



    

 


	16.	 	Applicable
    Law	 	This
    Agreement will be interpreted and enforced under the laws of the state of New York without reference to the conflicts of law
    provisions thereof.
	 	 	 	 	 
	17.	 	Regulatory
    Compliance	 	The
issuance of Shares pursuant to this Agreement shall be subject to full compliance with all applicable requirements of law and
the requirements of any stock exchange or interdealer quotation system upon which the Shares may be listed or traded.

	 	 	 	 	 
	18.	 	Binding
    Effect; No Third Party Beneficiaries	 	This
Agreement shall be binding upon and inure to the benefit of the Company and you and any respective heirs, representatives, successors
and permitted assigns. This Agreement shall not confer any rights or remedies upon any person other than the Company and you and
any respective heirs, representatives, successors and permitted assigns. The parties agree that this Agreement shall survive the
settlement or termination of the Option.

	 	 	 	 	 
	19.	 	Notice	 	Any
    notice to be given or delivered to the Company relating to this Agreement shall be in writing and addressed to the Company
    at its principal corporate offices. All notices shall be deemed effective upon personal delivery or upon deposit in the postal
    mail, postage prepaid and properly addressed to the Company. Any notice to be given or delivered to you relating to this Agreement
    may be delivered by electronic form including without limitation by email (including prospectuses required by the SEC) as
    well as all other documents that the Company is required to deliver to its security holders (including annual reports and
    proxy statements). The Company may also deliver these documents by posting them on a web site maintained by the Company or
    by a third party under contract with the Company.
	 	 	 	 	 
	20.	 	Voluntary
    Participant	 	You
acknowledge that you are voluntarily participating in the Plan.




 






    	 



    	 



    

 


	21.	 	No
    Rights to Future Awards	 	Your
    rights, if any, in respect of or in connection with this Option or any other Awards are derived solely from the discretionary
    decision of the Company to permit you to participate in the Plan and to benefit from a discretionary future Award. By accepting
    this Option, you expressly acknowledge that there is no obligation on the part of the Company to continue the Plan and/or
    grant any additional Awards to you or benefits in lieu of Options or any other Awards even if Awards have been granted repeatedly
    in the past. All decisions with respect to future Awards, if any, will be at the sole discretion of the Committee.
	 	 	 	 	 
	22.	 	Future
    Value	 	The
    future value of the underlying Shares is unknown and cannot be predicted with certainty. If the underlying Shares do not increase
    in value after the Date of Option Grant, the Option will have little or no value. If you exercise the Option and obtain Shares,
    the value of the Shares acquired upon exercise may increase or decrease in value, even below the Exercise Price. 
	 	 	 	 	 
	23.	 	No
    Advice Regarding Award	 	The
    Company has not provided any tax, legal or financial advice, nor has the Company made any recommendations regarding your participation
    in the Plan, or your acquisition or sale of the underlying Shares. You are hereby advised to consult with your own personal
    tax, legal and financial advisors regarding your participation in the Plan before taking any action related to the Plan.
	 	 	 	 	 
	24.	 	No
    Right to Damages	 	You
    will have no right to bring a claim or to receive damages if any portion of the Option is cancelled or expires unexercised.
    The loss of existing or potential profit in the Option will not constitute an element of damages in the event of the termination
    of your Service for any reason, even if the termination is in violation of an obligation of the Company Group to you.
	 	 	 	 	 
	25.	 	Data
    Privacy	 	By
    participating in this Plan, you acknowledge that, for the purpose of operating the Plan and the UK CSOP Schedule, the Company
    and/or any Group Company will collect and process information relating to you in accordance with the Company’s privacy
    notice. You understand that the Company holds certain personal information about you, including, but not limited to, name,
    home address and telephone number, date of birth, gender, social security or insurance number or other identification number,
    salary, nationality, job title, any shares of stock or directorships held in the Company, details of all Awards or any other
    entitlement to Shares awarded, cancelled, purchased, exercised, vested, unvested or outstanding in your favor for the purpose
    of implementing, managing and administering the Plan (“Data”). You understand that the Data may be transferred
    to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may
    be located in your country or elsewhere and that the recipient country may have different data privacy laws and protections
    than your country. You authorize the recipients to receive, possess, use, retain and transfer the Data, in electronic or other
    form, for the purposes of implementing, administering and managing your participation in the Plan, including any requisite
    transfer of such Data, as may be required to a broker or other third party with whom you may elect to deposit any Shares acquired
    under the Plan.



 






    	 



    	 



    

 


	26.	 	Other
    Information	 	You
agree to receive shareholder information, including copies of any annual report, proxy statement and periodic report, from the
Company’s website, if the Company wishes to provide such information through its website. You acknowledge that copies of
the Plan, Plan prospectus, Plan information and shareholder information are also available upon written or telephonic request
to the Plan’s administrator.

	 	 	 	 	 
	27.	 	Further
    Assistance	 	You
    agree to provide assistance reasonably requested by the Company in connection with actions taken by you while providing services
    to the Company, including but not limited to assistance in connection with any lawsuits or other claims against the Company
    arising from events during the period in which you rendered service to the Company.
	 	 	 	 	 
	28.	 	Legal
    Compliance	 	The
    Company Group is not responsible for your legal compliance requirements relating to this Option, including, but not limited
    to, tax reporting.
	 	 	 	 	 
	29.	 	Additional
    Conditions	 	If
    the Company shall determine, in its sole discretion, that the consent or approval of any governmental authority is necessary
    or desirable as a condition to the payment of benefits to you pursuant to the Plan, such payment shall not occur until such
    registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable
    to the Company.
	 	 	 	 	 
	30.	 	Enforcement	 	The
    Company will be entitled to enforce its rights under this Agreement specifically, to recover damages by reason of any breach
    of any provision of this Agreement and to exercise all other rights to which it may be entitled. You agree and acknowledge
    that money damages may not be an adequate remedy for breach of the provisions of this Agreement and that the Company may in
    its sole discretion apply to any court of law or equity of competent jurisdiction for specific performance and/or injunctive
    relief in order to enforce or prevent any violations of the provisions of this Agreement.



 






    	 



    	 



    

 


	31.	 	Nondisclosure
    of Confidential Information	 	You
    acknowledge that the businesses of the Company is highly competitive and that the Company’s strategies, methods, books,
    records, and documents, technical information concerning their products, equipment, services, and processes, procurement procedures
    and pricing techniques, the names of and other information (such as credit and financial data) concerning former, present
    or prospective customers and business affiliates, all comprise confidential business information and trade secrets which are
    valuable, special, and unique assets which the Company uses in their business to obtain a competitive advantage over competitors.
    You further acknowledge that protection of such confidential business information and trade secrets against unauthorized disclosure
    and use is of critical importance to the Company in maintaining its competitive position. You acknowledge that by reason of
    your duties to and association with the Company, you have had and will have access to and have and will become informed of
    confidential business information which is a competitive asset of the Company. You hereby agree that you will not, at any
    time during or after employment, make any unauthorized disclosure of any confidential business information or trade secrets
    of the Company, or make any use thereof, except in the carrying out of services responsibilities. You shall take all necessary
    and appropriate steps to safeguard confidential business information and protect it against disclosure, misappropriation,
    misuse, loss and theft. Confidential business information shall not include information in the public domain (but only if
    the same becomes part of the public domain through a means other than a disclosure prohibited hereunder). The above notwithstanding,
    a disclosure shall not be unauthorized if (i) it is required by law or by a court of competent jurisdiction or (ii) it is
    in connection with any judicial, arbitration, dispute resolution or other legal proceeding in which your legal rights and
    obligations as a service provider or under this Agreement are at issue; provided, however, that you shall, to the extent practicable
    and lawful in any such events, give prior notice to the Company of your intent to disclose any such confidential business
    information in such context so as to allow the Company an opportunity (which you will not oppose) to obtain such protective
    orders or similar relief with respect thereto as may be deemed appropriate. Any information not specifically related to the
    Company would not be considered confidential to the Company. In the event of any conflict in terms between this Section 31
    and the terms of any Company confidentiality or proprietary information agreement you have executed, the terms of such other
    confidentiality or proprietary information agreement shall prevail and govern.


____________________________


 




    	 



    	 



    

 


GAN
LIMITED


 


NOTICE
OF EXERCISE OF CSOP OPTION BY OPTIONEE


 


GAN
Limited


400
Spectrum Center Drive, Suite 1900


Irvine,
CA 92618

Attention: Corporate Secretary


 


	Re:	Exercise of CSOP Option to Purchase Shares of Company
Stock




 


 _______________________________________


 [PRINT NAME OF OPTIONEE]




 


Pursuant
to the CSOP Option Agreement dated ___________________, ______ between GAN Limited (the “Company”) and me, made pursuant
to the 2020 Equity Incentive Plan UK SUB-PLAN (CSOP) (the “Plan”), I hereby request to purchase _______ Ordinary Shares
(whole number only and must be not less than one hundred (100) Ordinary Shares or the remaining number of Vested Ordinary Shares
subject to this Option) of the Company (the “Shares”), at the exercise price of $__________ per Share. I am hereby
making full payment of the aggregate exercise price by one or more of the following forms of payment in accordance with the whole
number percentages that I have provided below. I further understand and agree that I will timely satisfy any and all applicable
tax withholding obligations as a condition of this Option exercise.


 


	Percentage

of Payment	Form of Payment As Provided In the CSOP Option Agreement
	 	 
	____%	Cash received
    directly from my brokerage account
	 	 
	____%	Cashless Exercise (if a public market then exists
for the Shares)
	100%	 




 


I
acknowledge that I have received, understand and continue to be bound by all of the terms and conditions set forth in the Plan,
Plan prospectus and in the CSOP Option Agreement.


 


Dated:
__________________


 


		 
	(Optionee’s Signature)	
	 	 	 
		 
	 	 
		 
	(Full Address)	




 


*THIS
NOTICE OF EXERCISE MAY BE REVISED BY THE COMPANY AT ANY TIME WITHOUT NOTICE.